Cirrhosis alcoholic and drugs of ingredients of albuterol - a phase IV clinical study of FDA data
Cirrhosis alcoholic is found among people who take drugs with ingredients of albuterol, especially for people who are male, 60+ old . This phase IV clinical study is created by eHealthMe based on reports of 193,951 people who have side effects when taking drugs with ingredients of albuterol from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Albuterol, Proventil, Ventolin.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
193,951 people reported to have side effects when taking drugs with ingredients of albuterol.
Among them, 8 people (0.0%) have Cirrhosis alcoholic
What is Cirrhosis alcoholic?
Cirrhosis alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism) is found to be associated with 362 drugs and 162 conditions by eHealthMe.
Number of reports submitted per year:
Gender of people who have Cirrhosis alcoholic when taking drugs with ingredients of albuterol *:
- female: 50 %
- male: 50 %
Age of people who have Cirrhosis alcoholic when taking drugs with ingredients of albuterol *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 40 %
- 60+: 60 %
Conditions people have *:
- Psoriasis (immune-mediated disease that affects the skin): 2 people, 25.00%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 12.50%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 12.50%
- Hepatocellular Carcinoma (liver cancer): 1 person, 12.50%
- Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 12.50%
Other drugs people take *:
- Vitamin D: 4 people, 50.00%
- Dulera: 3 people, 37.50%
- Lasix: 3 people, 37.50%
- Spiriva: 3 people, 37.50%
- Cosentyx: 2 people, 25.00%
- Metformin: 2 people, 25.00%
- Pantoprazole: 2 people, 25.00%
- Epipen: 2 people, 25.00%
- Aldactone: 2 people, 25.00%
- Constulose: 1 person, 12.50%
Other side effects people have besides Cirrhosis alcoholic *:
- Hepatic Neoplasm (liver tumour): 2 people, 25.00%
- Weakness: 2 people, 25.00%
- Overdose: 2 people, 25.00%
- Cardiac Failure: 2 people, 25.00%
- Hypophagia (reduced food intake): 2 people, 25.00%
- Hepatitis C: 2 people, 25.00%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 25.00%
- Non-Alcoholic Steatohepatitis (liver inflammation caused by a build up of fat in the liver): 2 people, 25.00%
- Sick Sinus Syndrome (a collection of heart rhythm disorders): 2 people, 25.00%
- Ascites (accumulation of fluid in the abdominal cavity): 2 people, 25.00%
* Approximation only. Some reports may have incomplete information.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of albuterol, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on albuterol. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.